Azelastine HCl 0.15% nasal spray showed rapid onset of action in relieving nasal symptoms of seasonal allergic rhinitis (SAR).

A new study illustrated that early azelastine nasal spray therapy might lower the SARS-CoV-2 load among virus-infected patients.

The demand for inhalation and nasal spray generic drugs is growing as these medications provide affordable and effective treatment options for respiratory ailments like asthma, COPD, and allergies.

A nasal spray can tamp down potentially fatal reactions, a boon to the many patients in crisis who fear using EpiPens. Neffy, a new device approved by the Food and Drug Administration, is the ...

Nasal Sprays Generic sumatriptan nasal spray is available in 5 or 20 milligram (mg) doses, which are administered into one nostril. You can also take a 10 mg dose by using the 5 mg dose in each ...

The global inhalation and nasal spray generic drugs market is projected to have a moderate-paced CAGR of 8.96% during the forecast period. The current valuation of the inhalation and nasal spray ...

The US Food and Drug Administration approved the first nasal spray epinephrine drug for severe allergic reactions known as anaphylaxis, providing a needle-free alternative to EpiPens and similar ...

The Food and Drug Administration approved the first needle-free alternative to the EpiPen, a single-use epinephrine nasal spray for emergency treatment of allergic reactions, including anaphylaxis.

Neffy, a single-dose nasal spray administered into one nostril, is approved for use in adult and pediatric patients who weigh at least 30 kilograms.

How rapid is the onset of effective action when using azelastine HCl 0.15% to relieve nasal symptoms of seasonal allergic rhinitis?